European Archives of Oto-Rhino-Laryngology

, Volume 271, Issue 9, pp 2443–2454 | Cite as

Feasibility of an interval, inspiration-triggered nocturnal odorant application by a novel device: a patient-blinded, randomised crossover, pilot trial on mood and sleep quality of depressed female inpatients

  • Frank Vitinius
  • Martin Hellmich
  • Annalena Matthies
  • Fabian Bornkessel
  • Heiner Burghart
  • Christian Albus
  • Karl-Bernd Huettenbrink
  • Julia Vent
Rhinology

Abstract

It has been suggested that certain odorants positively affect mood, but this has not yet been scientifically tested in humans. The aim of the current study was to demonstrate the feasibility of a new odorant applicator and to assess the effects of nocturnal intermittent rose odorant application on mood, and quality of sleep and dreams in depressed female inpatients. We hypothesised that mood as primary outcome will improve. Twenty-seven normosmic, 18- to 49-year-old female, depressed inpatients were investigated in a randomised, placebo-controlled, crossover study. Exclusion criteria were rhinitis, hyp- or anosmia. During sleep, an interval-controlled, inspiration-triggered applicator added rose concentrate to the inspirated air. There were three consecutive nights of each odorant and placebo application and a wash-out phase. Patients completed standardised questionnaires on mood, dreams, and sleep quality. Four patients dropped out (n = 1: non-compliance in filling in the questionnaires, n = 3: intolerance of nasal tube). Otherwise, this novel odorant applicator was well tolerated. Application of the odorant showed no significant mood differences between rose and placebo, however, some subdomains of sleep quality and mood showed a positive trend towards improvement by rose application. The feasibility of this new device and of nasal tubes could be shown. Odorant application is well tolerated. It may have a positive influence on quality of mood and sleep in depressed patients. A longer application phase is planned to obtain convincing evidence for our hypothesis.

Keywords

Odorant application Interval Depression Female inpatients Randomised controlled trial Crossover design 

Abbreviations

EMG

Electromyogram

GES

Recovery/recreation after sleep

SQ

Sleep quality

PSYA

Mental calmness before sleeping (Psychische Ausgeglichenheit vor dem Schlafenlegen)

PSYE

Mental exhaustion before sleeping (Psychisches Erschöpftsein vor dem Schlafenlegen)

PSS

Symptoms during sleep

PTSD

Posttraumatic stress disorder

Mood questionnaire

GS

Good–bad mood

WM

Alertness–fatigue

RU

Rest–agitation

Notes

Acknowledgments

The study was approved by the ethics committee of the University of Cologne Medical Centre (IRB Code 09-092). F.V. is supported by the German Federal Ministry of Research and Education (BMBF grant 01KN1106).The clinical testing and data acquisition was conducted in accordance with the, Good Clinical Practice (ICH-GCP)—Guidelines’ in principal and legal regulations. ICH International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.

References

  1. 1.
    Hufnagel LA (1992) Cortical ultrastructure and chemoreception in ciliated protists (Ciliophora). Microsc Res Tech 22(3):225–264PubMedCrossRefGoogle Scholar
  2. 2.
    Negoias S, Croy I, Gerber J et al (2010) Reduced olfactory bulb volume and olfactory sensitivity in patients with acute major depression. Neuroscience 169(1):415–421PubMedCrossRefGoogle Scholar
  3. 3.
    Mendlewicz J, Crisafulli C, Calati R et al (2012) Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression. Neurosci Lett 516(1):85–88PubMedCrossRefGoogle Scholar
  4. 4.
    Dalton P (2000) Psychophysical and behavioral characteristics of olfactory adaptation. Chem Senses 25(4):487–492PubMedCrossRefGoogle Scholar
  5. 5.
    Warrenburg S (2005) Effects of fragrance on emotions: moods and physiology. Chem Senses 30(Suppl 1):i248–i249PubMedCrossRefGoogle Scholar
  6. 6.
    Umezu T (2000) Behavioral effects of plant-derived essential oils in the geller type conflict test in mice. Jpn J Pharmacol 83(2):150–153PubMedCrossRefGoogle Scholar
  7. 7.
    Umezu T, Ito H, Nagano K et al (2002) Anticonflict effects of rose oil and identification of its active constituents. Life Sci 72(1):91–102PubMedCrossRefGoogle Scholar
  8. 8.
    de Almeida RN, Motta SC, de Brito FC, Catallani B, Leite JR (2004) Anxiolytic-like effects of rose oil inhalation on the elevated plus-maze test in rats. Pharmacol Biochem Behav 77(2):361–364PubMedCrossRefGoogle Scholar
  9. 9.
    Komiya M, Takeuchi T, Harada E (2006) Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behav Brain Res 172(2):240–249PubMedCrossRefGoogle Scholar
  10. 10.
    Ramezani R, Moghimi A, Rakhshandeh H, Ejtehadi H, Kheirabadi M (2008) The effect of Rosa damascena essential oil on the amygdala electrical kindling seizures in rat. Pak J Biol Sci 11(5):746–751PubMedCrossRefGoogle Scholar
  11. 11.
    Haze S, Sakai K, Gozu Y, Moriyama M (2010) Grapefruit oil attenuates adipogenesis in cultured subcutaneous adipocytes. Planta Med 76(10):950–955PubMedCrossRefGoogle Scholar
  12. 12.
    Haze S, Sakai K, Gozu Y (2002) Effects of fragrance inhalation on sympathetic activity in normal adults. Jpn J Pharmacol 90(3):247–253PubMedCrossRefGoogle Scholar
  13. 13.
    Van der Watt G, Janca A (2008) Aromatherapy in nursing and mental health care. Contemp Nurse 30(1):69–75PubMedCrossRefGoogle Scholar
  14. 14.
    Van der Watt G, Laugharne J, Janca A (2008) Complementary and alternative medicine in the treatment of anxiety and depression. Curr Opin Psychiatry 21(1):37–42PubMedCrossRefGoogle Scholar
  15. 15.
    Park MK, Lee ES (2004) The effect of aroma inhalation method on stress responses of nursing students. Taehan Kanho Hakhoe Chi 34(2):344–351PubMedGoogle Scholar
  16. 16.
    Goel N, Kim H, Lao RP (2005) An olfactory stimulus modifies nighttime sleep in young men and women. Chronobiol Int 22(5):889–904PubMedCrossRefGoogle Scholar
  17. 17.
    Stuck BA, Weitz H, Hormann K, Maurer JT, Hummel T (2006) Chemosensory event-related potentials during sleep—a pilot study. Neurosci Lett 406(3):222–226PubMedCrossRefGoogle Scholar
  18. 18.
    Stuck BA, Stieber K, Frey S et al (2007) Arousal responses to olfactory or trigeminal stimulation during sleep. Sleep 30(4):506–510PubMedGoogle Scholar
  19. 19.
    Schredl M, Atanasova D, Hormann K, Maurer JT, Hummel T, Stuck BA (2009) Information processing during sleep: the effect of olfactory stimuli on dream content and dream emotions. J Sleep Res 18(3):285–290PubMedCrossRefGoogle Scholar
  20. 20.
    Vinnik E, Itskov PM, Balaban E (2012) β- and γ-band EEG power predicts illusory auditory continuity perception. J Neurophysiol 108(10):2717–2724. doi: 10.1152/jn.00196.2012 Google Scholar
  21. 21.
    Vinnik E, Antopolskiy S, Itskov PM, Diamond ME (2012) Auditory stimuli elicit hippocampal neuronal responses during sleep. Front Syst Neurosci 6:49PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Arzi A, Sela L, Green A, Givaty G, Dagan Y, Sobel N (2010) The influence of odorants on respiratory patterns in sleep. Chem Senses 35(1):31–40PubMedCrossRefGoogle Scholar
  23. 23.
    Arzi A, Shedlesky L, Ben-Shaul M et al (2012) Humans can learn new information during sleep. Nat Neurosci 15(10):1460–1465. doi: 10.1038/nn.3193 Google Scholar
  24. 24.
    Hautzinger M, Bailer M, Worall H, Keller F (1995) Beck-depression-inventory: test manual (Beck-Depressions-Inventar (BDI)—Testhandbuch), 2nd edn. Hans Huber, BernGoogle Scholar
  25. 25.
    Hummel T, Kobal G, Gudziol H, Mackay-Sim A (2007) Normative data for the “Sniffin’Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects. Eur Arch Otorhinolaryngol 264(3):237–243PubMedCrossRefGoogle Scholar
  26. 26.
    Hummel T, Konnerth CG, Rosenheim K, Kobal G (2001) Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110(10):976–981PubMedGoogle Scholar
  27. 27.
    Goertelmeyer R (1986) Schlaffragebogen A und B. In: Collegium Internale Psychiatriäe Scalarium (ed) International Psyciatric Scales (Internationale Skalen für Psychiatrie). Beltz Test GmbH, WeinheimGoogle Scholar
  28. 28.
    Steyer R, Schwenkmezger P, Notz P, Eid M (1997) MDBF—Mehrdimensionaler Befindlichkeitsfragebogen; multidimensional comfort questionnaire. Manual. Hogrefe Verlag für PsychologieGoogle Scholar
  29. 29.
    Hills M, Armitage P (2004) The two-period cross-over clinical trial. 1979. Br J Clin Pharmacol 58(7):S703–S716PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Hills M, Armitage P (1979) The two-period cross-over clinical trial. Br J Clin Pharmacol 8(1):7–20PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Frasnelli J, Hummel T (2005) Olfactory dysfunction and daily life. Eur Arch Otorhinolaryngol 262(3):231–235PubMedCrossRefGoogle Scholar
  32. 32.
    Temmel AF, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T (2002) Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 128(6):635–641PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Frank Vitinius
    • 1
  • Martin Hellmich
    • 3
  • Annalena Matthies
    • 5
  • Fabian Bornkessel
    • 6
  • Heiner Burghart
    • 4
  • Christian Albus
    • 1
  • Karl-Bernd Huettenbrink
    • 2
  • Julia Vent
    • 2
    • 7
  1. 1.Department of Psychosomatic Medicine and PsychotherapyUniversity of Cologne Medical CenterCologneGermany
  2. 2.Department of Otorhinolaryngology, Head and Neck SurgeryUniversity of Cologne Medical CenterCologneGermany
  3. 3.Institute of Medical Statistics, Informatics and EpidemiologyUniversity of Cologne Medical CenterCologneGermany
  4. 4.Burghart Messtechnik GmbHWedelGermany
  5. 5.Private Practice: Dr. med. dent. Luca ReimannRösrathGermany
  6. 6.Department of Complementary and Integrative Medicine, Alfred Krupp von Bohlen and Halbach FoundationKliniken Essen-Mitte, University of Duisburg-EssenEssenGermany
  7. 7.University of Heidelberg Medical Centre at Mannheim (UMM)MannheimGermany

Personalised recommendations